Home

SHARON TETLOW

CIK 1328565 · Acting CFO & Treasurer · last filed 2026-06-18

SHARON TETLOW is an Acting CFO & Treasurer who has filed 17 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for GPCR, was dated Jun 18, 2026. Current disclosed insider exposure totals $4.3K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.3K

Companies

4

Total Filings

17

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GPCR Director — $47.13 — $0 3 2026-06-18
DICE Therapeutics, Inc. (DICE) Delisted Director 0 $47.55 $0 $0 3 2023-08-09
CBIO Director 242 $17.93 $4.3K $0 5 2021-07-02
CELL GENESYS INC (CEGE) Delisted SVP & CFO 0 — — $0 5 2009-10-15

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 GPCR Grant (A) — $0 EDGAR
2025-06-25 GPCR Grant (A) — $0 EDGAR
2024-06-27 GPCR Grant (A) — $0 EDGAR
2023-08-09 DICE Therapeutics, Inc. (DICE) Delisted Disp (D) −49,841 $0 EDGAR
2022-06-08 DICE Therapeutics, Inc. (DICE) Delisted Grant (A) — $0 EDGAR
2021-09-16 DICE Therapeutics, Inc. (DICE) Delisted Grant (A) — $0 EDGAR
2021-07-02 CBIO Grant (A) — $0 EDGAR
2020-07-02 CBIO Grant (A) +1,703 $0 EDGAR
2020-06-12 CBIO Grant (A) — $0 EDGAR
2020-04-03 CBIO Grant (A) +1,932 $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.